Pharmaceutical manufacturer, one of America’s largest producers of prescription opioids, is in talks with its major investors about selling some or all of the company’s business units, potentially leading to its exit from the opioid business, according to people familiar with the discussions.Our Intelligence. Your Advantage.
Sign in or subscribe for access to peerless insight & analysis, curated data & interactives, and networking events.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: Investingcom - 🏆 450. / 53 続きを読む »
ソース: aldotcom - 🏆 82. / 68 続きを読む »